George Yancopoulos

George Yancopoulos
Born1959 (age 65–66)
EducationColumbia University (BA, MD, PhD)
OccupationBiomedical scientist
EmployerRegeneron

George D. Yancopoulos (born 1959) is a Greek-American biomedical scientist who is the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals.

Yancopoulos is an elected member of the National Academy of Sciences, a fellow of the American Academy of Arts and Sciences (AAAS), and the holder of more than 100 patents. He is a principal inventor and developer of Regeneron's ten FDA-approved or -authorized treatments, as well as of Regeneron's foundational technologies for target and drug development, such as its proprietary TRAP technology, and the VelociGene and VelocImmune antibody technologies.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.